Figure 4.
Quantitative levels of Th2 cytokine (IL-4) in (A) granulomas derived from Taenia crassiceps infected, wild type versus SP-Precursor knockout and NK1 receptor knockout mice. *P< 05, IL-4 levels in infected, SP-Precursor knockout-derived granulomas versus wild type-derived granulomas, †P< .05, IL-4 levels in infected, NK1 knockout-derived granulomas versus wild type-derived granulomas. (B) Early versus late granulomas derived from Taenia crassiceps infected, wild type versus SP-Precursor knockout and NK1 receptor knockout mice., *P< 05, IL-4 levels in infected, early stage versus late stage SP-Precursor knockout-derived granulomas, †P< .05, IL-4 levels in infected, early stage versus late stage NK1 knockout-derived granulomas.